New York University- Langone Health

New York, New York 10017

9 studies enrolling now · 49 studies all time

What they study most

AML (Acute Myeloid Leukemia), Acute Myeloid Leukemia, Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome, Adult, Acute Respiratory Failure, Adenoid Cystic Carcinoma, Amyloid Cardiomyopathy, Amyloid Cardiomyopathy, Transthyretin-Related, Amyloidosis, Androgen-Resistant Prostatic Neoplasms, Atherosclerotic Cardiovascular Disease, Atypical Parkinsonism

Studies at this site

• A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 — Recruiting now
• ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant — Recruiting now
• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors — Recruiting now
• Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD — Recruiting now
• Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors — Recruiting now
• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD — Recruiting now
• ARrest RESpiraTory Failure From PNEUMONIA — Stopped early
• A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. — Running, not enrolling
• A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients — Starting soon
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors — Running, not enrolling
• Trial of Parkinson's And Zoledronic Acid — Completed
• A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) — Running, not enrolling
• A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA) — Running, not enrolling
• ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS — Completed
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Add-on Reparixin in Adult Patients With ARDS — Completed
• Efficacy in iNPH Shunting (PENS) Trial — Running, not enrolling
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer — Running, not enrolling
• Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study — Enrolling by invitation
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) — Running, not enrolling
• Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study — Completed
• A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain. — Completed
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine — Completed
• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants — Running, not enrolling
• Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer — Completed
• Interventions Made to Preserve Cognitive Function — Stopped early
• Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI) — Completed
• Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) — Completed
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis — Completed
• BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007 — Completed
• Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors — Stopped early
• A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) — Stopped early
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy — Completed
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed
• Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery — Completed
• MSCs in COVID-19 ARDS — Stopped early
• Implementing a Digital Child Mental Health Screening, Literacy, and Management Tool in Faith-Based Settings — Completed
• Direct Acting Antiviral-Post Authorization Safety Study — Completed
• A Controlled Trial of Losartan in Posttraumatic Stress Disorder — Completed
• Making Sense of Dyspnea Assessment — Completed